Tag Archives: Igenica Biotherapeutics

October, 2015

  • 28 October

    Igenica Partners with MedImmune to Research Anti-SAIL ADCs

    BURLINGAME, Calif.–(BUSINESS WIRE)–Igenica Biotherapeutics, Inc., a company focused on the discovery and development of innovative antibody-based therapies for the treatment of cancer, announced today that it has entered into an oncology research agreement with MedImmune, the global biologics research and development arm of AstraZeneca (NYSE: AZN). Igenica and MedImmune will …